ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Tyrosine kinase receptor B attenuates liver fibrosis by inhibiting TGF-β/SMAD signaling

Song, Yu; Wei, Jiayi; Li, Rong; Fu, Ruifeng; Han, Pei; Wang, Heming; Zhang, Guangcong; Li, Shuyu; Chen, Sinuo; Liu, Zhiyong; Zhao, Yicheng; Zhu, Changfeng; Zhu, Jimin; Zhang, Shuncai; Pei, Hao; Cheng, Jiefei; Wu, Jian; Dong, Ling*; Song, Guangqi*; Shen, Xizhong*; Yao, Qunyan*复旦大学; 吉林大学; 中国医学科学院
Hepatology2023-11DOI: 10.1097/HEP.0000000000000319
6被引12阅读
引用收藏
分享

摘要

Background and Aims: Liver fibrosis is a leading indicator for increased mortality and long-term comorbidity in NASH. Activation of HSCs and excessive extracellular matrix production are the hallmarks of liver fibrogenesis. Tyrosine kinase receptor (TrkB) is a multifunctional receptor that participates in neurodegenerative disorders. However, paucity of literature is available about TrkB function in liver fibrosis. Herein, the regulatory network and therapeutic potential of TrkB were explored in the progression of hepatic fibrosis. @@@ Methods and Results: The protein level of TrkB was decreased in mouse models of CDAHFD feeding or carbon tetrachloride-induced hepatic fibrosis. TrkB suppressed TGF-beta-stimulated proliferation and activation of HSCs in 3-dimensional liver spheroids and significantly repressed TGF-beta/SMAD signaling pathway either in HSCs or in hepatocytes. The cytokine, TGF-beta, boosted Nedd4 family interacting protein-1 (Ndfip1) expression, promoting the ubiquitination and degradation of TrkB through E3 ligase Nedd4- 2. Moreover, carbon tetrachloride intoxication-induced hepatic fibrosis in mouse models was reduced by adeno-associated virus vector serotype 6 (AAV6)-mediated TrkB overexpression in HSCs. In addition, in murine models of CDAHFD feeding and Gubra-Amylin NASH (GAN), fibrogenesis was reduced by adeno-associated virus vector serotype 8 (AAV8)-mediated TrkB overexpression in hepatocytes. @@@ Conclusion: TGF-beta stimulated TrkB degradation through E3 ligase Nedd4-2 in HSCs. TrkB overexpression inhibited the activation of TGF-beta/SMAD signaling and alleviated the hepatic fibrosis both in vitro and in vivo. These findings demonstrate that TrkB could be a significant suppressor of hepatic fibrosis and confer a potential therapeutic target in hepatic fibrosis.

学科与关键词

关键词
TRKBSTRATEGY
相关
加载中…
  • Fibroblast growth factor 18 attenuates liver fibrosis and HSCs activation via the SMO-LATS1-YAP pathway
    Tong, Gaozan; Chen, Xixi; Lee, Jongsuk; Fan, Junfu; Li, Santie; Zhu, Kunxuan; Hu, Zijing; Mei, Lin; Sui, Yanru; Dong, Yonggan; Chen, Rui; Jin, Zhouxiang; Zhou, Bin; Li, Xiaokun; Wang, Xu*; Cong, Weitao*; Huang, Peijun*; Jin, Litai*Pharmacological Research, 2022, 178: 106139.被引 8
  • The S100 calcium binding protein A11 promotes liver fibrogenesis by targeting TGF-β signaling
    Zhu, Tingting; Zhang, Linqiang; Li, Chengbin; Tan, Xiaoqiong; Liu, Jing; Li, Huiqin; Fan, Qijing; Zhang, Zhiguo; Zhan, Mingfeng; Fu, Lin; Luo, Jinbo; Geng, Jiawei*; Wu, Yingjie*; Zou, Xiaoju*; Liang, Bin*Journal of Genetics and Genomics, 2022, 49(4): 338-349.被引 9
  • Design of a highly potent GLP-1R and GCGR dual-agonist for recovering hepatic fibrosis
    Song, Nazi; Xu, Hongjiao; Liu, Jiahua; Zhao, Qian; Chen, Hui; Yan, Zhibin; Yang, Runling; Luo, Zhiteng; Liu, Qi; Ouyang, Jianmei; Wu, Shuohan; Luo, Suijia; Ye, Shuyin; Lin, Runfeng; Sun, Xi; Xie, Junqiu; Lan, Tian; Wu, Zhongdao*; Wang, Rui*; Jiang, Xianxing*Acta Pharmaceutica Sinica B, 2022, 12(5): 2443-2461.被引 9
查看全部 →

发表信息

论文状态
公开发表
期刊
Hepatology
发表日期
2023-11
卷期
第 78 卷, 第 5 期
页码
1433-1447
DOI
10.1097/HEP.0000000000000319
语言
ENGLISH
成果收录
SCIE
资助标注
China Postdoctoral Science Foundation [2020M671010]; Horizontal Project with Otsuka of Joint Training Postdoctoral Program [H2020-016]; Shanghai Science and Technology Committee [22140900700]; Natural Science Foundation of Shanghai [20ZR1411200]; National Natural Science Foundation of China [81700550, 81871997, 82170624]

作者

  • S

    Song, Yu (第一作者)

    fudan univ

  • W

    Wei, Jiayi

    fudan univ

查看全部 21 位作者收起作者
  • L

    Li, Rong

  • F

    Fu, Ruifeng

  • H

    Han, Pei

  • W

    Wang, Heming

    fudan univ

  • Z

    Zhang, Guangcong

    fudan univ

  • L

    Li, Shuyu

    fudan univ

  • C

    Chen, Sinuo

    fudan univ

  • L

    Liu, Zhiyong

    fudan univ

  • Z

    Zhao, Yicheng

    jilin univ

  • Z

    Zhu, Changfeng

    fudan univ

  • Z

    Zhu, Jimin

    fudan univ

  • Z

    Zhang, Shuncai

    fudan univ

  • P

    Pei, Hao

  • C

    Cheng, Jiefei

    shanghai univ tradit chinese med

  • W

    Wu, Jian

    cams · fudan univ

  • D

    Dong, Ling (通讯)

    fudan univ

  • S

    Song, Guangqi (通讯)

    fudan univ

  • S

    Shen, Xizhong (通讯)

    fudan univ

  • Y

    Yao, Qunyan (通讯)

    fudan univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417